|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| Amortization of acquisition-related inventory fair value step-up | |||||
| Provision for credit losses | |||||
| Provision for warranties | |||||
| Deferred compensation expense (benefit) | |||||
| Share-based compensation | |||||
| Deferred tax provision (benefit) | |||||
| Gain on sale of property and equipment, net | |||||
| Non-cash curtailment and settlement loss on pension and postretirement benefits, net | |||||
| Asset impairment charges | |||||
| Other impairment charges | |||||
| Amortization of debt issuance costs | |||||
| Distributions to deferred compensation programs' participants | |||||
| Change in operating assets and liabilities, excluding the effects of acquisitions: | |||||
| Purchase of trading securities, net | |||||
| Receivables and other contract assets | |||||
| Inventories | |||||
| Prepaid expenses | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued retirement benefit costs | |||||
| Accrued loss reserves | |||||
| Accrued employee related liabilities | |||||
| Other accrued liabilities | |||||
| Accrued product warranty | |||||
| Customer deposits | |||||
| Income taxes payable/prepaid | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Price adjustment on prior sale of subsidiary | |||||
| Expenditures for property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from insurance | |||||
| Purchase of investments | |||||
| Sale of investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of dividends | |||||
| Proceeds from borrowings on credit facilities and bank loans | |||||
| Repayments of borrowings on credit facilities and bank loans | |||||
| Payment of debt issuance costs | |||||
| Sale of Company stock by deferred compensation programs, net | |||||
| Withholding tax paid upon vesting of share-based compensation awards | |||||
| Repurchase of Company stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash | |||||
| (Decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Cash Flow Information | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes paid, net | |||||
| Supplemental disclosures of non-cash items | |||||
| Capital expenditures in accounts payable | |||||
| Additions to right-of-use assets and lease liabilities | |||||
Loading...